EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
LOADING
|||
Cash Flow Performance
Trending lower, below historical average.
Left:
||||
Free cash flow yield
Latest
-31.06%
↓ 44% below average
Average (9y)
-21.59%
Historical baseline
Range
High:9.15%
Low:-51.42%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -31.06% | -16823.8% |
| 2023 | -0.18% | +99.6% |
| 2022 | -51.42% | -260.1% |
| 2021 | -14.28% | +18.5% |
| 2020 | -17.52% | +50.2% |
| 2019 | -35.20% | -53.7% |
| 2018 | -22.90% | +32.9% |
| 2017 | -34.15% | -86.0% |
| 2016 | -18.36% | -300.6% |
| 2015 | 9.15% | - |